Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds hormone or other secreted growth regulatory factor,...
Patent
1996-09-11
1998-07-21
Spector, Lorraine M.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds hormone or other secreted growth regulatory factor,...
4241451, 53038824, 5303892, A61K 39395
Patent
active
057831874
ABSTRACT:
Connective Tissue Growth Factor (CTGF) is a polypeptide growth factor for connective tissue cells. CTGF is related immunologically and biologically to PDGF, but is the product of a distinct gene. CTGF, nucleic acids encoding CTGF, means for producing CTGF, anti-CTGF antibodies, diagnostic and therapeutic methods for using CTGF, and methods for inhibition or stimulation of CTGF activity are disclosed.
REFERENCES:
patent: 5094941 (1992-03-01), Hart
patent: 5147294 (1992-09-01), Smith et al.
patent: 5408040 (1995-04-01), Grotendorst et al.
patent: 5418135 (1995-05-01), Pang
Shimokado et al., Cell 43:277-286, Nov. 1985.
Campochiaro et al., Exp. Eye Res. 49:217-227, 1989.
Matsuoka et al., Proc. Nat. Acad. Sci. 86:4416-4420, Jun. 1989.
Ryseck, R.P. et al., Cell Growth and Differentiation 2:225-233, May 1991.
Bradham, Jr. Douglas M.
Grotendorst Gary R.
Spector Lorraine M.
University of South Florida
LandOfFree
Treatment of cell proliferative disorders using antibodies which does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cell proliferative disorders using antibodies which, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cell proliferative disorders using antibodies which will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1644345